{"id":"https://openalex.org/W1990708897","doi":"https://doi.org/10.1046/j.1365-2141.2001.02530.x","title":"The impact of attaining a minimal disease state after high\u2010dose melphalan and autologous transplantation for multiple myeloma","display_name":"The impact of attaining a minimal disease state after high\u2010dose melphalan and autologous transplantation for multiple myeloma","alternate_titles":[],"publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W1990708897","doi":"https://doi.org/10.1046/j.1365-2141.2001.02530.x","mag":"1990708897","pmid":"https://pubmed.ncbi.nlm.nih.gov/11260088"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2141.2001.02530.x","doi":"https://doi.org/10.1046/j.1365-2141.2001.02530.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2001.02530.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990708897"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034560778","display_name":"Faith E. Davies","orcid":"https://orcid.org/0000-0002-3971-2393","observed_orcids":["https://orcid.org/0000-0002-3971-2393"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Faith E. Davies","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, Leeds LS1, UK","Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, Leeds LS1, UK","institution_ids":["https://openalex.org/I130828816"]},{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042104200","display_name":"Peter D. Forsyth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter D. Forsyth","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001511648","display_name":"Andy C. Rawstron","orcid":"https://orcid.org/0000-0003-0798-9790","observed_orcids":["https://orcid.org/0000-0003-0798-9790"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew C. Rawstron","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063301766","display_name":"Roger G. Owen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger G. Owen","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053124814","display_name":"Guy Pratt","orcid":"https://orcid.org/0000-0002-6937-2852","observed_orcids":["https://orcid.org/0000-0002-6937-2852"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guy Pratt","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004618702","display_name":"Paul Evans","orcid":"https://orcid.org/0000-0002-7915-0946","observed_orcids":["https://orcid.org/0000-0002-7915-0946"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul A. S. Evans","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101680772","display_name":"Stephen John Richards","orcid":"https://orcid.org/0000-0002-8421-5353","observed_orcids":["https://orcid.org/0000-0002-8421-5353"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen J. Richards","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053100242","display_name":"Mark Trehane Drayson","orcid":"https://orcid.org/0000-0002-1528-7564","observed_orcids":["https://orcid.org/0000-0002-1528-7564"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Drayson","raw_affiliation_strings":["Department of Immunology, University of Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, University of Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083761453","display_name":"Graeme Smith","orcid":"https://orcid.org/0000-0003-1694-4885","observed_orcids":["https://orcid.org/0000-0003-1694-4885"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Graeme M. Smith","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086212361","display_name":"Peter John Selby","orcid":"https://orcid.org/0000-0002-3782-069X","observed_orcids":["https://orcid.org/0000-0002-3782-069X"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter J. Selby","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112827367","display_name":"J. Anthony Child","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Anthony Child","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100632493","display_name":"Gareth John Morgan","orcid":"https://orcid.org/0000-0002-4271-6360","observed_orcids":["https://orcid.org/0000-0002-4271-6360","https://orcid.org/0000-0001-7073-2723"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gareth J. Morgan","raw_affiliation_strings":["Academic Department of Haematology and Oncology, University of Leeds, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Department of Haematology and Oncology, University of Leeds, and","institution_ids":["https://openalex.org/I130828816"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100632493"],"corresponding_institution_ids":["https://openalex.org/I130828816"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":4.5039,"has_fulltext":false,"cited_by_count":117,"citation_normalized_percentile":{"value":0.95081322,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"112","issue":"3","first_page":"814","last_page":"819"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/high-dose-melphalan","display_name":"high-dose melphalan","score":0.9599999785423279},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9399999976158142},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.9110000133514404},{"id":"https://openalex.org/keywords/response-criteria","display_name":"response criteria","score":0.6100000143051147},{"id":"https://openalex.org/keywords/immunofixation","display_name":"immunofixation","score":0.9729999899864197},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7990000247955322},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.6859999895095825}],"concepts":[{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.9350293874740601},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8141434788703918},{"id":"https://openalex.org/C2778808339","wikidata":"https://www.wikidata.org/wiki/Q2785444","display_name":"Immunofixation","level":5,"score":0.7400927543640137},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7340182065963745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6157476305961609},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.557695209980011},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5345569849014282},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5233854055404663},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5061034560203552},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48144668340682983},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.45816829800605774},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.4545922875404358},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.45218461751937866},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31989774107933044},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.08503001928329468},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.0640365481376648},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001536","descriptor_name":"Bence Jones Protein","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004586","descriptor_name":"Electrophoresis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008558","descriptor_name":"Melphalan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008775","descriptor_name":"Methylprednisolone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D014182","descriptor_name":"Transplantation, Autologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1365-2141.2001.02530.x","doi":"https://doi.org/10.1046/j.1365-2141.2001.02530.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.2001.02530.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:11260088","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11260088","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/62abccaf-0592-4c79-97db-0433eff10fe5","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/62abccaf-0592-4c79-97db-0433eff10fe5","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Davies, FE, Forsyth, PD, Rawstron, AC, Owen, RG, Pratt, G, Evans, PAS, Richards, SJ, Drayson, M, Smith, GM, Selby, PJ, Child, JA & Morgan, GJ 2001, 'The impact of attaining a minimal disease state after high dose melphalan and autologous transplantation for multiple myeloma', British Journal of Haematology, vol. 112, pp. 814-819. https://doi.org/10.1046/j.1365-2141.2001.02530.x","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W20342555","https://openalex.org/W60687421","https://openalex.org/W112843385","https://openalex.org/W147513325","https://openalex.org/W179685316","https://openalex.org/W181450122","https://openalex.org/W1483653400","https://openalex.org/W1840931904","https://openalex.org/W1914496726","https://openalex.org/W1978377409","https://openalex.org/W1978444073","https://openalex.org/W2004323633","https://openalex.org/W2008804413","https://openalex.org/W2017706891","https://openalex.org/W2026295989","https://openalex.org/W2072858641","https://openalex.org/W2083144698","https://openalex.org/W2115015071","https://openalex.org/W2130358507","https://openalex.org/W2154135294","https://openalex.org/W2163549274","https://openalex.org/W2267664734","https://openalex.org/W2290337133","https://openalex.org/W2333363976"],"related_works":["https://openalex.org/W2523933478","https://openalex.org/W1840931904","https://openalex.org/W134047030","https://openalex.org/W2603130351","https://openalex.org/W2322962980","https://openalex.org/W2001779883","https://openalex.org/W1992231323","https://openalex.org/W1791616244","https://openalex.org/W2150254829","https://openalex.org/W1977950751"],"abstract_inverted_index":{"Initial":[0],"studies":[1],"with":[2,77,110,157,162,164],"high-dose":[3],"therapy":[4],"(HDT)":[5],"in":[6,30,155],"myeloma":[7],"suggest":[8],"some":[9],"beneficial":[10],"effects":[11],"of":[12,33,56,90,118,141,215],"attaining":[13],"a":[14,97,139,149,165],"complete":[15],"response":[16,34,57,99,106,119,223],"(CR);":[17],"however,":[18],"the":[19,31,54,116,195,212,216],"effect":[20,55],"on":[21,58,194,232],"survival":[22,59,130,134,197],"is":[23],"difficult":[24],"to":[25,28,70,100,182,188,203],"assess":[26],"owing":[27],"inconsistencies":[29],"definition":[32],"between":[35],"studies.":[36],"We":[37],"have":[38],"analysed":[39],"96":[40],"newly":[41],"diagnosed":[42],"patients":[43,156,163,234],"aged":[44],"less":[45],"than":[46],"65":[47],"years":[48],"who":[49,235],"received":[50,74],"HDT":[51,121],"and":[52,63,88,132,144,198,225],"assessed":[53],"using":[60],"electrophoresis,":[61],"immunofixation":[62,228],"fluorescent":[64,199],"IgH":[65,200],"polymerase":[66],"chain":[67],"reaction":[68],"(PCR)":[69],"define":[71,183,189],"CR.":[72,184],"Patients":[73],"induction":[75],"chemotherapy":[76],"C-VAMP":[78,101],"(adriamycin,":[79],"vincristine,":[80],"methylprednisolone,":[81],"cyclophosphamide)":[82],"followed":[83],"by":[84],"melphalan":[85],"200":[86],"mg/m2":[87],"reinfusion":[89],"peripheral":[91],"blood":[92],"stem":[93],"cells.":[94],"There":[95,147],"was":[96,148,175,180],"high":[98],"[CR":[102],"=":[103,108,123,126,172],"24%,":[104],"partial":[105],"(PR)":[107],"64%],":[109],"all":[111,233],"but":[112],"one":[113],"patient":[114],"improving":[115],"depth":[117],"after":[120],"(CR":[122],"69%,":[124],"PR":[125,166],"31%).":[127],"The":[128,185],"progression-free":[129],"(PFS)":[131],"overall":[133,196],"(OS)":[135],"were":[136],"excellent":[137],"at":[138],"median":[140],"46.4":[142],"months":[143],"72+":[145],"months.":[146],"trend":[150],"towards":[151],"an":[152,158],"improved":[153],"PFS":[154],"immunofixation-negative":[159],"CR":[160,190],"compared":[161],"(49.4":[167],"months,":[168],"41.14":[169],"months;":[170],"P":[171],"0.26).":[173],"This":[174,209],"not":[176,192],"evident":[177],"when":[178],"electrophoresis":[179,237],"used":[181,187],"method":[186],"did":[191],"impact":[193],"PCR":[201],"failed":[202],"add":[204],"any":[205],"additional":[206],"prognostic":[207],"information.":[208],"study":[210],"supports":[211],"widespread":[213],"use":[214],"European":[217],"Bone":[218],"Marrow":[219],"Transplantation":[220],"group":[221],"(EBMT)":[222],"criteria":[224],"suggests":[226],"that":[227],"should":[229],"be":[230],"performed":[231],"become":[236],"negative.":[238]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990708897","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
